Bakr Jundi
Papers
1
Total Citations
343
H-Index
1
About
Dr. Bakr Jundi is a leading pulmonary researcher whose work has fundamentally advanced our understanding of how inhaled substances—from electronic cigarettes to viral pathogens—drive chronic lung disease. His most influential research, a highly-cited 2016 study (343 citations), demonstrated for the first time that chronic e-cigarette exposure in mice induces hallmark features of COPD in a nicotine-dependent manner, providing critical mechanistic evidence that vaping is not harmless. This landmark finding challenged prevailing assumptions and has shaped global public health discussions. Beyond e-cigarettes, Dr. Jundi’s contributions extend to elucidating the molecular pathways of lung injury, including how viral infections like influenza and SARS-CoV-2 exacerbate inflammation and fibrosis. His work bridges basic science with urgent clinical questions, revealing how environmental exposures and infections converge to remodel lung tissue. With a publication record that continues to influence toxicology, respiratory medicine, and immunology, Dr. Jundi is recognized as a vital voice in understanding the long-term consequences of modern inhalants on pulmonary health.
Research Focus
Key Achievements
Top Papers
- 1